Aurora Cannabis (NYSE:ACB – Get Free Report) and biote (NASDAQ:BTMD – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, analyst recommendations, profitability and earnings.
Valuation & Earnings
This table compares Aurora Cannabis and biote’s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Aurora Cannabis | $211.59 million | 1.43 | -$1.36 billion | ($0.52) | -1.44 |
| biote | $164.96 million | 2.36 | -$970,000.00 | ($2.20) | -2.39 |
biote has lower revenue, but higher earnings than Aurora Cannabis. biote is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Aurora Cannabis | -88.27% | -30.47% | -16.50% |
| biote | -13.05% | -37.29% | 22.26% |
Insider & Institutional Ownership
11.2% of Aurora Cannabis shares are held by institutional investors. Comparatively, 23.0% of biote shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by company insiders. Comparatively, 16.6% of biote shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Analyst Ratings
This is a summary of current recommendations for Aurora Cannabis and biote, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Aurora Cannabis | 0 | 0 | 0 | 0 | N/A |
| biote | 0 | 0 | 3 | 0 | 3.00 |
Aurora Cannabis presently has a consensus target price of $4.05, suggesting a potential upside of 439.21%. biote has a consensus target price of $9.67, suggesting a potential upside of 84.13%. Given Aurora Cannabis’ higher probable upside, equities research analysts clearly believe Aurora Cannabis is more favorable than biote.
Volatility & Risk
Aurora Cannabis has a beta of 2.58, indicating that its share price is 158% more volatile than the S&P 500. Comparatively, biote has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500.
Summary
biote beats Aurora Cannabis on 7 of the 13 factors compared between the two stocks.
About Aurora Cannabis
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Leduc, Canada.
About biote
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irvine, Texas.
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
